APA (7th ed.) Citation

EJ, T., DJ, M., HC, H., ER, P., CL, G., DJ, C., . . . Investigators, D. T. a. R. G. S. E. T. (2001). Comparison of two platelet gylcoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. New England Journal of Medicine, 344(25), 1888.

Chicago Style (17th ed.) Citation

EJ, Topol, et al. "Comparison of Two Platelet Gylcoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization." New England Journal of Medicine 344, no. 25 (2001): 1888.

MLA (9th ed.) Citation

EJ, Topol, et al. "Comparison of Two Platelet Gylcoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization." New England Journal of Medicine, vol. 344, no. 25, 2001, p. 1888.